EDP Sciences logo
Search
Menu
All issues Volume 85 / No 1-2 (January-April 2005) Lait, 85 1-2 (2005) 99-111 References
Free Access
Issue
Lait
Volume 85, Number 1-2, January-April 2005
International Symposium on Propionibacteria and Bifidobacteria: dairy and probiotic applications
Page(s) 99 - 111
DOI https://doi.org/10.1051/lait:2004025
References of Lait 85 99-111
  1. Adawi D., Molin G., Jeppsson B., Inhibition of nitric oxide production and the effects of arginine and Lactobacillus administration in an acute liver injury model, Ann. Surg. 228 (1998) 748-755 [CrossRef].
  2. Alvarez S., Medici M., Vintini E., Oliver G., de Ruiz Holgado A.P., Perdigon G., Effect of the oral administration of Propio-nibacterium IgA levels and on the prevention of enteric infection in mice, Microbiol. Alim. Nutr. 14 (1996) 237-243.
  3. Avice J.C., Ourry A., Lainé P., Roland N., Louahlia S., Roussel E., Brookes S., Boucaud J., A rapid and reliable method for NO quantification and 15NO/14NO determination using isotope ratio mass sprectrometry: an application for the detection of NO synthesis in propionibacteria, Rapid Commun. Mass Spectrom. 13 (1999) 1197-1200 [CrossRef].
  4. Blottière H.M., Buecher B., Galmiche J.P., Cherbut C., Molecular analysis of the effect of short-chain fatty acids on intestinal cell proliferation, Proc. Nutr. Soc. 62 (2003) 101-106 [CrossRef].
  5. Bouglé D., Roland N., Lebeurrier F., Arhan P., Effect of propionibacteria supplementation on fecal bifidobacteria and segmental colonic transit time in healthy human subjects, Scand. J. Gastroenterol. 34 (1999) 144-148 [CrossRef].
  6. Cherbut C., Michel C., Lecannu G., The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats, J. Nutr. 133 (2003) 21-27.
  7. Cummins C.S., Johnson J.L., Genus I., Propionibacterium Orla-Jensen 1909, 337AL, in: Sneath P.H.A., Mair N.S., Sharpe M.E. (Eds.), Bergey's Manual of Systematic Bacteriology, Vol. 2, Williams & Wilkins, Baltimore, USA, 1986, pp. 1346-1353.
  8. Den Hond E., Hiele M., Evenepoel P., Peeters M., Ghoos Y., Rutgeerts P., In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis, Gastroenterol. 115 (1998) 584-590.
  9. Hosoi T., Goto H., Arisawa T., Niwa Y., Okada N., Ohmiya N., Hayakawa T., Role of nitric oxide synthase inhibitor in experimental colitis induced by 2,4,6-trinitrobenzene sulphonic acid in rats, Clin. Exp. Pharmacol. Physiol. 28 (2001) 9-12 [CrossRef].
  10. Huang Y., Adams M.C., An in vitro model for investigating intestinal adhesion of potential dairy propionibacteria probiotic strains using cell line C2BBe1, Lett. Appl. Microbiol. 36 (2003) 213-216.
  11. Jan G., Belzacq A.S., Haouzi D., Rouault A., Metivier D., Kroemer G., Brenner C., Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria, Cell Death Differ. 9 (2002) 179-188 [CrossRef].
  12. Jan G., Leverrier P., Proudy I., Roland N., Survival and beneficial effects of propionibacteria in the human gut: in vivo and in vitro investigations, Lait 82 (2002) 131-144 [EDP Sciences] [CrossRef].
  13. Ji X.B., Hollocher T.C., Reduction of nitrite to nitric oxide by enteric bacteria, Biochem. Biophys. Res. Commun. 157 (1988) 106-108.
  14. Jouany J.P., Volatile fatty acid and alcohol determination in digestive contents, silage juices, bacterial cultures and anaerobic fermentor contents, Sci. Aliments 2 (1982) 131-144.
  15. Kaneko T., Mori H., Iwata M., Meguro S., Growth stimulator for bifidobacteria produced by Propionibacterium freudenreichii and several intestinal bacteria, J. Dairy Sci. 77 (1994) 393-404.
  16. Kaspar H.F., Nitrite reduction to nitrous oxide by propionibacteria: detoxication mechanism, Arch. Microbiol. 133 (1982) 126-130 [CrossRef].
  17. Krawisz J.B., Sharon P., Stenson W.E., Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity, Gastroenterol. 87 (1984) 1344-1350.
  18. Kubes P., McCafferty D.M., Nitric oxide and intestinal inflammation, Amer. J. Med. 109 (2000) 150-158.
  19. Lamine F., Fioramonti J., Bueno L., Nepveu F., Cauquil E., Lobysheva I., Eutamène H., Théodorou V., Nitric oxide released by Lactobacillus farciminis improves TNBS-induced colitis in rats, Scand. J. Gastroenterol. 39 (2004) 37-45 [CrossRef]
  20. Le Blay G.M., Michel C.D., Blottière H.M., Cherbut C.J., Raw potato starch and short-chain fructo-oligosaccharides affect the composition and metabolic activity of rat intestinal microbiota differently depending on the caecocolonic segment involved, J. Appl. Microbiol. 94 (2003) 312-320 [CrossRef].
  21. Madsen K.L., Doyle J.S., Jewell L.D., Tavernini M.M., Fedorak R.N., Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice, Gastroenterol. 116 (1999) 1107-1114.
  22. Malik A.C., Reinbold G.W., Vedamuthu E.R., An evaluation of the taxonomy of Propioni-bacterium, Can. J. Microbiol. 14 (1968) 1185-1191.
  23. Mao Y., Nobaek S., Kasravi B., Adawi D., Stenram U., Molin G., Jeppsson B., The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats, Gastroenterol. 111 (1996) 334-344.
  24. Matsuki T., Watanabe K., Fujimoto J., Kado Y., Takada T., Matsumoto K., Tanaka R., Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria, Appl. Environ. Microbiol. 70 (2004) 167-173 [CrossRef].
  25. McCafferty D.M., Mudgett J.S., Swain M.G., Kubes P., Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation, Gastroenterol. 112 (1997) 1022-1027.
  26. Menchen L.A., Colon A.L., Moro M.A., Leza J.C., Lizasoain I., Menchen P., Alvarez E., Lorenzo P., N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats, Life Sci. 69 (2001) 479-491 [CrossRef].
  27. Morata de Ambrosini V., Gonzalez S., Perdigon G., de Ruiz Holgado A.P., Oliver G., Immunostimulating activity of cell walls from lactic acid bacteria and related species, Food Agric. Immunol. 10 (1998) 183-191.
  28. Moreau N.M., Champ M.M., Goupry S.M., Le Bizec B.J., Krempf M., Nguyen P.G., Dumon H.J., Martin L.J., Resistant starch modulates in vivo colonic butyrate uptake and its oxidation in rats with dextran sulfate sodium-induced colitis, J. Nutr. 134 (2004) 493-500.
  29. Mori H., Sato Y., Taketomo N., Kamiyama T., Yoshiyama Y., Meguro S., Sato H., Kaneko T., Isolation and structural identification of bifidogenic growth stimulator produced by Propionibacterium freuden-reichii, J. Dairy Sci. 80 (1997) 1959-1964.
  30. Morris G.P., Beck P.L., Herridge M.S., Depew W.T., Szewczuk M.R., Wallace J.L., Hapten-induced model of chronic inflammation and ulceration in the rat colon, Gastroenterol. 96 (1989) 795-803.
  31. Osman N., Adawi D., Ahrne S., Jeppsson B., Molin G., Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium, Dig. Dis. Sci. 49 (2004) 320-327 [CrossRef].
  32. Ouwehand A.C., Suomalainen T., Tölkkö S., Salminen S., In vitro adhesion of propio-nic acid bacteria to human intestinal mucus, Lait 82 (2002) 123-130 [EDP Sciences] [CrossRef].
  33. Parham N.J., Gibson G.R., Microbes involved in dissimilatory nitrate reduction in the human large intestine, FEMS Microbiol. Ecol. 31 (2000) 21-28 [CrossRef].
  34. Pavlick K.P., Laroux F.S., Fuseler J., Wolf R.E., Gray L., Hoffman J., Grisham M.B., Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease, Free Radic. Biol. Med. 33 (2002) 311-322.
  35. Perez Chaia A., Nader de Macias M.E., Oliver G., Propionibacteria in the gut: effect on some metabolic activities of the host, Lait 75 (1995) 435-445.
  36. Perez Chaia A., Zarate G., Oliver G., The probiotic properties of propionibacteria, Lait 79 (1999) 175-185.
  37. Perner A., Rask-Madsen J., The potential role of nitric oxide in chronic inflammatory bowel disorders, Aliment Pharmacol. Ther. 13 (1999) 135-144 [CrossRef].
  38. Rachmilewitz D., Stamler J.S., Bachwich D., Karmeli F., Ackerman Z., Podolsky D.K., Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease, Gut 36 (1995) 718-723.
  39. Rigaud D., Angel L.A., Cerf M., Carduner M.J., Melchior J.C., Sautier C., Rene E., Apfelbaum M., Mignon M., Mechanisms of decreased food intake during weight loss in adult Crohn's disease patients without ob-vious malabsorption, Amer. J. Clin. Nutr. 60 (1994) 775-781.
  40. Saito Y., Sakamoto M., Takizawa S., Benno Y., Monitoring the cell number and viability of Lactobacillus helveticus GCL1001 in human feces by PCR methods, FEMS Microbiol. Lett. 231 (2004) 125-130 [CrossRef].
  41. Sartor R.B., Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebio-tics, Gastroenterol. 126 (2004) 1620-1633.
  42. Schiffrin E.J., Brassart D., Servin A.L., Rochat F., Donnet-Hughes A., Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection, Amer. J. Clin. Nutr. 66 (1997) 515S-520S.
  43. Vardareli E., Dundar E., Angin K., Saricam T., Inal M., Effects of intrarectal and intraperitoneal N(G)-nitro-L-arginine methyl ester treatment in 2,4,6-trinitrobenzenesulfonic acid induced colitis in rats, Exp. Toxicol. Pathol. 55 (2003) 271-276.
  44. Wallace J.L., Vergnolle N., Muscara M.N., Asfaha S., Chapman K., McKnight W., Del Soldato P., Morelli A., Fiorucci S., Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats, Gastroenterol. 117 (1999) 557-566.
  45. Wolf G., Arendt E.K., Pfähler U., Hammes WP., Heme-dependent and heme-independent nitrite reduction by lactic acid bacteria results in different N-containing products, Int. J. Food Microbiol. 10 (1990) 323-330 [CrossRef].
  46. Xu J., Verstraete W., Evaluation of nitric oxide production by lactobacilli, Appl. Microbiol. Biotechnol. 56 (2001) 504-507 [CrossRef].
  47. Yoshida Y., Iwai A., Itoh K., Tanaka M., Kato S., Hokari R., Miyahara T., Koyama H., Miura S., Kobayashi M., Role of inducible nitric oxide synthase in dextran sulphate sodium-induced colitis, Aliment Pharmacol. Ther. 14 (2000) 26-32 [CrossRef].
  48. Zarate G., Morata de Ambrosini V.I., Perez Chaia A., Gonzalez S.N., Adhesion of dairy propionibacteria to intestinal epithelial tissue in vitro and in vivo, J. Food Prot. 65 (2002) 534-539.
  49. Zumft W.G., Cell biology and molecular basis of denitrification, Microbiol. Mol. Biol. Rev. 61 (1997) 533-616.